Growth Metrics

Unicycive Therapeutics (UNCY) Prepaid Assets (2020 - 2026)

Unicycive Therapeutics posted quarterly Prepaid Assets of $181000.0 for Q1 2026, down 86.77% year-on-year from $1.4 million in Q1 2025, and down 45.48% on a QoQ basis from $332000.0 in Q4 2025.

Unicycive Therapeutics (UNCY) has 7 years of Prepaid Assets data on file, last reported at $181000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets fell 86.77% year-over-year to $181000.0; the trailing twelve-month figure through Mar 2026 stood at $181000.0 (down 86.77% YoY), and the FY2025 full-year result was $332000.0, down 93.09% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $181000.0, down from $332000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.2 million in Q2 2025 and bottomed at $15000.0 in Q2 2024.
  • The 5-year median for Prepaid Assets is $1.8 million (2022), against an average of $2.0 million.
  • The widest annual swing landed in 2024, when Prepaid Assets sank 99.52%; it then soared 47893.33% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $2.2 million in 2022, then tumbled by 87.67% to $270000.0 in 2023, then soared by 1680.0% to $4.8 million in 2024, then slumped by 93.09% to $332000.0 in 2025, then tumbled by 45.48% to $181000.0 in 2026.
  • The last three Prepaid Assets figures came in at $181000.0 (Q1 2026), $332000.0 (Q4 2025), and $489000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Unicycive Therapeutics 181.94 Mn 127.36 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 181,000.00
Dec 31, 2025 332,000.00
Sep 30, 2025 489,000.00
Jun 30, 2025 7.20 Mn
Mar 31, 2025 1.37 Mn
Dec 31, 2024 4.81 Mn
Sep 30, 2024 397,000.00
Jun 30, 2024 15,000.00
Mar 31, 2024 146,000.00
Dec 31, 2023 270,000.00
Sep 30, 2023 4.22 Mn
Jun 30, 2023 3.11 Mn
Mar 31, 2023 1.85 Mn
Dec 31, 2022 2.19 Mn
Sep 30, 2022 2.95 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 1.84 Mn
Dec 31, 2021 1.83 Mn
Sep 30, 2021 58,000.00
Jun 30, 2021 10,000.00
Dec 31, 2020 4,000.00